日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Commentary on: the management of patients with gastric intestinal metaplasia

关于胃肠化生患者管理的评论

Graham, David Y; Lee, Yi-Chia

Seroprevalence of Helicobacter pylori Infection Among Asymptomatic Patients Served by a Safety-Net Healthcare System

安全网医疗保健系统服务的无症状患者中幽门螺杆菌感染的血清阳性率

Thrift, Aaron P; Dinarvand, Peyman; Juarez, Luis; Brown, Jourdan; Avila, Daniel; Zafiro Garcia-Villanueva, Jennifer Mistica; Danek, Lisa C; Mahmood, Hammad; Porter, Thomas; Gotschall, Ann; Pirzada, Noreen F; Rueda, Jaime J; Lu, Lee B; Ali, Afroze; Anyakorah, Ijeoma; Bhattarai, Sanjana J; Fatima, Anees; Garcia, Jessica; Nguyen, Hung V; Joshi, Bharat; Juneja, Malvika; Lateef, Misba S; Mujtaba, Najda; Nambi, Preethi V; Orr, Jay S; Rahman, Huma; Nguyen, Stephanie; Waqar, Amna; Chen, Yanyan; Graham, David Y; El-Serag, Hashem B; Tan, Mimi C

Dairy Consumption and the Colonic Mucosa-Associated Gut Microbiota in Humans-A Preliminary Investigation

乳制品摄入与人类结肠黏膜相关肠道菌群——一项初步研究

Chen, Ellie; Ajami, Nadim J; White, Donna L; Liu, Yanhong; Gurwara, Shawn; Hoffman, Kristi; Graham, David Y; El-Serag, Hashem B; Petrosino, Joseph F; Jiao, Li

Elastic Cytomatrix Dynamics Influences Metabolic Rate and Tumor Microenvironment Formation

弹性细胞基质动力学影响代谢率和肿瘤微环境形成

Shaiken, Tattym E; Nurkenov, Tulendy T; Kurmanbayeva, Meruyert S; Graham, David Y

Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High-Dosage L. reuteri in H. pylori-Infected Adults

幽门螺杆菌感染成人接受短期质子泵抑制剂治疗(伴或不伴高剂量罗伊氏乳杆菌)后肠道微生物群的恢复力

Bibbò, Stefano; Ahlström, Gustav; Pes, Giovanni Mario; Graham, David Y; Engstrand, Lars; Merola, Elettra; Dore, Maria Pina

Eradication Rates of Empiric Helicobacter pylori Treatment Regimens by Race/Ethnicity in a Predominantly Immigrant U.S. Population

美国以移民为主的人群中,不同种族/族裔人群对经验性幽门螺杆菌治疗方案的根除率

Kim, Min J; Gonzalez, Isiah; Choi, Nia M; Graham, David Y; El-Serag, Hashem B; Tan, Mimi C

40 years after the discovery of Helicobacter Pylori: Performing optimized "subtraction" for clinical eradication

幽门螺杆菌发现40年后:开展优化的“减法”以进行临床根除

Hu, Yi; Du, Ren-Chun; Lai, Yong-Kang; Hu, Yu-Xin; Zhu, Yu-Chen; Zhou, Yan-An; Shu, Chun-Xi; Zhou, Bo; Ling, Li-Xiang; Shu, Xu; Xie, Yong; Lau, James Y W; Zhu, Yin; Graham, David Y; Lu, Nong-Hua

Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease

一项随机、双盲、安慰剂对照研究,评估抗分枝杆菌疗法(RHB-104)治疗活动性克罗恩病的疗效

Graham, David Y; Naser, Saleh A; Borody, Thomas; Hebzda, Zbigniew; Sarles, Harry; Levenson, Scott; Hardi, Robert; Arłukowicz, Tomasz; Svorcan, Petar; Fathi, Reza; Bibliowicz, Aida; Anderson, Patricia; McLean, Patrick; Fehrmann, Clara; Harris, M Scott; Zhao, Shuhong; Kalfus, Ira N

Self-Correcting Method for Highly Effective Office-Based Helicobacter pylori Therapy Using Cumulative Test of Cure Data

利用累积治愈率检验数据,实现高效门诊幽门螺杆菌治疗的自我纠正方法

Dore, Maria Pina; Hernaez, Ruben; Graham, David Y

Lack of Detection of Norwalk Virus in Saliva Samples From a Controlled Human Infection Model

在受控的人体感染模型中,唾液样本中未检测到诺如病毒

Atmar, Robert L; Neill, Frederick H; Hayes, Nicole M; Opekun, Antone R; Graham, David Y; Estes, Mary K; Ramani, Sasirekha